Corporate Profile

Inotiv, Inc., is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. To learn more about our portfolio of services, click here.

  • Click here for our latest investor presentation.

Investor News

  • Click here for the webcast of Inotiv’s presentation at the UBS Global Healthcare Conference on Tuesday, May 24, 2022, at 7:45am ET.
  • Click here for the recording of the Q2 FY 2022 Financial Results Conference held Thursday, May 12, 2022, at 4:30pm ET.
  • Click here for the recording of the Q1 FY 2022 Financial Results Conference call held Thursday, February 10, 2022, at 4:30pm ET.
  • Click here for the recording of the Q4 FY 2021 Financial Results Conference Call held Thursday, December 16, 2021, at 4:30pm ET.
  • Click here to view Form 8937, Report of Organizational Actions Affecting Basis of Securities, for the Merger with Envigo RMS Holdings Corp on November 5, 2021.
  • Click here for the webcast of Inotiv’s presentation at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 12:20pm GMT.  Click here to view the presentation deck.
  • Click here for the recording of the Envigo Acquisition Conference Call held on Tuesday, September 21, 2021, at 10:00am ET. Click here to view the presentation deck.
  • Click here for the recording of our Q3 FY 2021 Financial Results Conference Call held Wednesday, August 11, 2021, at 4:30pm ET.
  • Click here for the recording of our Q2 FY 2021 Financial Results Conference Call held on Wednesday, May 5, 2021, at 4:30pm ET.
  • Click here to listen to the audio recording of the BASi/Inotiv 2021 Annual Meeting of Shareholders held on Thursday, March 18, 2021.
  • Click here to listen to the March 9-10, 2021, webcast of BASi/Inotiv’s presentation at the H.C. Wainwright Global Life Sciences Virtual Conference. Click here to view the presentation deck.
  • Click here for the recording of our Q1 FY 2021 Financial Results Conference Call held on Tuesday, February 9, 2021, at 4:30pm ET.
  • Click here to listen to the September 16, 2020, recording of BASi/Inotiv’s presentation at the H.C. Wainwright 22nd Annual Global Investment Conference. Click here to view the presentation deck.

SEC Filings / SEC 16 Filings

Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results

May 12, 2022​

Results

Investor Relations
Beth A. Taylor, Chief Financial Officer
Inotiv, Inc.
765.497.8381
Email

Kalle Ahl, CFA
The Equity Group
212.836.9614
Email

Devin Sullivan
The Equity Group
212.836.9608
Email